dc.contributor.author | Emet, Samim | |
dc.contributor.author | ARMAN, Yusuf | |
dc.contributor.author | Cakmak, R. | |
dc.contributor.author | Tukek, Tufan | |
dc.contributor.author | OZGUN, Ersin | |
dc.contributor.author | Alibeyoglu, A. | |
dc.contributor.author | YURUYEN, G. | |
dc.contributor.author | AKARSU, M. | |
dc.contributor.author | OZCAN, M. | |
dc.contributor.author | ALTUN, O. | |
dc.contributor.author | Kose, M. | |
dc.contributor.author | Onur, I. | |
dc.contributor.author | Atici, A. | |
dc.date.accessioned | 2021-03-04T08:10:01Z | |
dc.date.available | 2021-03-04T08:10:01Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | Atici A., Emet S., Cakmak R., YURUYEN G., Alibeyoglu A., AKARSU M., ARMAN Y., Kose M., OZGUN E., OZCAN M., et al., "Type I cardiorenal syndrome in patients with acutely decompensated heart failure: the importance of new renal biomarkers.", European review for medical and pharmacological sciences, cilt.22, sa.11, ss.3534-3543, 2018 | |
dc.identifier.issn | 1128-3602 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_61e6b6cd-7726-461f-b85d-8990fa9741b6 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/68208 | |
dc.identifier.uri | https://doi.org/10.26355/eurrev_201806_15180 | |
dc.description.abstract | OBJECTIVE: Type 1 cardiorenal syndrome (CRS) is an acute renal failure in patients with acute decompensated heart failure with an incidence of 24% to 45%. The aim of our study was to investigate the significance of new renal biomarkers to predict type 1 CRS. | |
dc.language.iso | eng | |
dc.subject | Eczacılık | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Temel Bilimler | |
dc.subject | Temel Eczacılık Bilimleri | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Farmakoloji ve Toksikoloji | |
dc.subject | FARMAKOLOJİ VE ECZACILIK | |
dc.title | Type I cardiorenal syndrome in patients with acutely decompensated heart failure: the importance of new renal biomarkers. | |
dc.type | Makale | |
dc.relation.journal | European review for medical and pharmacological sciences | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 22 | |
dc.identifier.issue | 11 | |
dc.identifier.startpage | 3534 | |
dc.identifier.endpage | 3543 | |
dc.contributor.firstauthorID | 84785 | |